吗啡市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

吗啡市场按剂型(注射剂、口服片剂和其他剂型)、应用(疼痛管理和腹泻抑制剂)和地理细分。

吗啡市场快照

Morphine Market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

在预测期内,所研究的吗啡市场预计将以近 7.5% 的复合年增长率增长。促成市场增长的主要因素是吗啡用于疼痛管理的使用增加。吗啡被认为是治疗疼痛最有效的药物之一。此外,它们用于治疗与晚期医学疾病相关的严重疼痛和慢性疼痛,被认为是世界大部分地区的标准做法。此外,关节炎、肘痛、纤维肌痛和骨质疏松症等骨科疾病的发病率不断上升,是造成吗啡市场增长的主要因素。根据世界卫生组织的数据,到 2050 年,全世界将有 1.3 亿人患有骨关节炎,其中4000万人将因疾病严重致残。随着患者数量的增加,吗啡在疼痛管理中的使用增加正在推动市场增长。然而,与吗啡摄入相关的处方药滥用和风险因素是限制市场增长的担忧。

报告范围

根据报告的范围,吗啡是一种从鸦片中提取的镇痛和麻醉药物,用于治疗中度至重度疼痛。该报告按剂型、应用和地理位置进行了细分。

By Dosage Form
Injection
Oral Tablets
Other Dosage Forms
By Application
Pain Management
Cancer Pain
Neuropathic Pain
Osteoarthritis Pain
Other Pain Managements
Diarrhea Suppressant
Cold and Cough Suppressant
Other Diarrhea Suppressants
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

疼痛管理部门主导吗啡市场

吗啡用于缓解中度至重度疼痛。吗啡缓释片剂和胶囊剂仅用于缓解使用其他止痛药无法控制的剧烈疼痛。根据 2017 年发表在《内科医学档案》上的一项最新研究,据估计,美国 15% 至 20% 的医生就诊涉及阿片类药物处方。阿片类药物在急性术后环境中起着至关重要的作用,以提供足够的镇痛作用。根据 2018 年的国家卫生服务报告,在英国,超过 1000 万人患有关节炎或其他影响关节的类似疾病。此外,国际骨质疏松症基金会指出,骨质疏松症被认为是女性最严重的公共卫生问题之一,在美国和欧洲,每年影响超过 30% 的人口,并导致多处骨折。根据统计数据,疼痛疾病患病率的增加增加了细分市场的增长。

Morphine Market

北美在市场上占主导地位,预计在预测期内也会如此

预计北美将在预测期内主导整个市场。市场增长是由于关键参与者的存在、该地区慢性病的高发病率以及成熟的医疗保健基础设施等因素造成的,这些因素是其在市场上占有很大份额的一些关键因素。此外,有益的政府举措和研究合作伙伴数量的增加是预计增加市场增长的一些驱动因素。在该地区,由于支持性医疗保健政策、大量患者和发达的医疗保健市场,美国的份额最大。

Morphine Market geo.png

竞争格局

吗啡市场竞争适度,由几个主要参与者组成。目前主导市场的一些公司是 MALLINCKRODT PHARMACEUTICALS、辉瑞公司、Sun Pharmaceutical Industries Ltd、Verve Health Care Ltd、Mayne Pharma Group Limited、Daiichi Sankyo Inc.、Hikma Pharmaceuticals USA Inc. 和 Mylan NV。

主要玩家

  1. MALLINCKRODT PHARMACEUTICALS

  2. Pfizer Inc.

  3. Sun Pharmaceutical Industries Ltd.

  4. Verve Health Care Ltd.

  5. Allergan Plc

Morphine Market.png

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Prevalence of Orthopedic Diseases and Chronic Pain

      2. 4.2.2 Increasing Palliative Care Facilities

    3. 4.3 Market Restraints

      1. 4.3.1 Prescription Drug Abuse

      2. 4.3.2 Risk Factors Associated With Intake of Morphine

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Dosage Form

      1. 5.1.1 Injection

      2. 5.1.2 Oral Tablets

      3. 5.1.3 Other Dosage Forms

    2. 5.2 By Application

      1. 5.2.1 Pain Management

        1. 5.2.1.1 Cancer Pain

        2. 5.2.1.2 Neuropathic Pain

        3. 5.2.1.3 Osteoarthritis Pain

        4. 5.2.1.4 Other Pain Managements

      2. 5.2.2 Diarrhea Suppressant

      3. 5.2.3 Cold and Cough Suppressant

      4. 5.2.4 Other Diarrhea Suppressants

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East & Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East & Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 MALLINCKRODT PHARMACEUTICALS

      2. 6.1.2 Pfizer Inc.

      3. 6.1.3 Sun Pharmaceutical Industries Ltd

      4. 6.1.4 Allergan

      5. 6.1.5 Sandoz Canada Inc.

      6. 6.1.6 Mayne Pharma Group Limited

      7. 6.1.7 Daiichi Sankyo Inc.

      8. 6.1.8 Verve Health Care Ltd

      9. 6.1.9 Hikma Pharmaceuticals USA Inc.

      10. 6.1.10 Mylan NV

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Morphine Market market is studied from 2018 - 2026.

The Morphine Market is growing at a CAGR of 7.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

MALLINCKRODT PHARMACEUTICALS, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Verve Health Care Ltd., Allergan Plc are the major companies operating in Morphine Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!